NEW YORK (GenomeWeb) -- Quest Diagnostics today reported that its second quarter revenues were up 1 percent year over year, meeting analysts' consensus estimate.

Quest's revenues for the three months ended June 30 were $1.93 billion compared to $1.90 billion for the second quarter in 2014. The top-line figure matched Wall Street's expectation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.